AZITHROMYCIN MONOHYDRATE

AZITHROMYCIN MONOHYDRATE was reported 42736 times

AZITHROMYCIN MONOHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 123 0.8786
1 VAGINAL FLATULENCE 155 0.5116
2 CONGENITAL HIATUS HERNIA 105 0.4605
3 TOTAL LUNG CAPACITY INCREASED 122 0.4485
4 HEART SOUNDS 40 0.4167
5 PULMONARY VASCULITIS 174 0.3234
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 168 0.3212
7 TOTAL LUNG CAPACITY ABNORMAL 110 0.2828
8 CAPILLARITIS 56 0.2029
9 DELIVERY 126 0.1912
10 SPIROMETRY ABNORMAL 107 0.1789
11 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 37 0.1674
12 PROLONGED EXPIRATION 43 0.1641
13 MITE ALLERGY 104 0.1588
14 MYCOBACTERIUM ABSCESSUS INFECTION 91 0.1273
15 PULMONARY FUNCTION TEST ABNORMAL 197 0.1264
16 MYCOBACTERIUM AVIUM COMPLEX INFECTION 318 0.1183
17 MYCOTIC ALLERGY 100 0.1170
18 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 106 0.1143
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 83 0.1132
20 DUST ALLERGY 109 0.1111
21 NEURITIS 163 0.1055
22 RHINOCEREBRAL MUCORMYCOSIS 36 0.1037
23 FEMALE GENITAL TRACT FISTULA 160 0.0936
24 ABORTION INCOMPLETE 154 0.0827
25 BRONCHIECTASIS 549 0.0814
26 CONJUNCTIVITIS ALLERGIC 117 0.0789
27 BREATH SOUNDS ABNORMAL 379 0.0768
28 PHOTODERMATOSIS 32 0.0758
29 CHRONIC SINUSITIS 280 0.0745
30 RESPIRATORY SYMPTOM 210 0.0738
31 RHINITIS ALLERGIC 321 0.0720
32 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 143 0.0701
33 RADICULOPATHY 170 0.0644
34 BRONCHIAL WALL THICKENING 45 0.0626
35 NASAL POLYPS 301 0.0611
36 PULMONARY CAVITATION 53 0.0609
37 FORCED EXPIRATORY VOLUME DECREASED 170 0.0599
38 FULL BLOOD COUNT ABNORMAL 611 0.0577
39 CHEST X-RAY ABNORMAL 173 0.0564
40 PROCTITIS 156 0.0556
41 MALIGNANT MELANOMA IN SITU 68 0.0549
42 BONE DEMINERALISATION 58 0.0548
43 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 58 0.0546
44 MYCOBACTERIAL INFECTION 93 0.0539
45 TOTAL LUNG CAPACITY DECREASED 86 0.0538
46 OBSTRUCTIVE AIRWAYS DISORDER 592 0.0532
47 ATYPICAL MYCOBACTERIAL INFECTION 75 0.0530
48 BACTERIAL DISEASE CARRIER 38 0.0521
49 BILIARY DYSKINESIA 88 0.0518
50 LUNG TRANSPLANT REJECTION 34 0.0515
51 OTOTOXICITY 93 0.0502
52 CYSTIC FIBROSIS 277 0.0500
53 LUNG OPACITY 124 0.0470
54 EAR PRURITUS 159 0.0453
55 HYPERPARATHYROIDISM SECONDARY 110 0.0439
56 IMMUNE RECONSTITUTION SYNDROME 56 0.0434
57 BRONCHIAL HYPERREACTIVITY 51 0.0424
58 MYCOPLASMA INFECTION 32 0.0410
59 REBOUND ACID HYPERSECRETION 124 0.0410
60 MACULAR DEGENERATION 487 0.0407
61 NEPHROGENIC ANAEMIA 188 0.0405
62 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 36 0.0403
63 HILAR LYMPHADENOPATHY 34 0.0386
64 STENOTROPHOMONAS INFECTION 52 0.0383
65 PULMONARY ALVEOLAR HAEMORRHAGE 205 0.0365
66 CHOLECYSTITIS CHRONIC 241 0.0360
67 NORMOCHROMIC NORMOCYTIC ANAEMIA 108 0.0359
68 SPUTUM DISCOLOURED 340 0.0358
69 RALES 207 0.0356
70 BRONCHIAL SECRETION RETENTION 45 0.0353
71 PNEUMONIA PSEUDOMONAL 53 0.0345
72 SPUTUM RETENTION 33 0.0333
73 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 175 0.0321
74 UPPER-AIRWAY COUGH SYNDROME 264 0.0320
75 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 544 0.0320
76 BLOOD LACTIC ACID INCREASED 166 0.0315
77 JAUNDICE CHOLESTATIC 108 0.0305
78 NEUROLOGICAL SYMPTOM 173 0.0302
79 VASCULITIS 352 0.0302
80 RHONCHI 41 0.0297
81 INFUSION SITE DISCHARGE 52 0.0296
82 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 77 0.0289
83 SPUTUM INCREASED 62 0.0286
84 PLEURITIC PAIN 79 0.0286
85 PNEUMATOSIS INTESTINALIS 81 0.0284
86 SARCOIDOSIS 134 0.0282
87 TACHYARRHYTHMIA 64 0.0256
88 DEAFNESS NEUROSENSORY 83 0.0252
89 GALLBLADDER INJURY 48 0.0246
90 HYPOMANIA 90 0.0244
91 BENIGN PROSTATIC HYPERPLASIA 126 0.0244
92 DEAFNESS BILATERAL 41 0.0241
93 MUCORMYCOSIS 62 0.0238
94 PREMATURE DELIVERY 372 0.0233
95 WHEEZING 1373 0.0231
96 END STAGE RENAL DISEASE 406 0.0222
97 PULMONARY FUNCTION TEST DECREASED 96 0.0219
98 HAEMOPTYSIS 601 0.0215
99 ISCHAEMIC CARDIOMYOPATHY 66 0.0215
100 ORAL CANDIDIASIS 277 0.0210
101 HYPERCAPNIA 63 0.0209
102 CARDIAC MURMUR 180 0.0208
103 ARTERIOSCLEROSIS CORONARY ARTERY 137 0.0207
104 HALLUCINATIONS, MIXED 83 0.0197
105 PSEUDOMONAS INFECTION 169 0.0197
106 PRODUCTIVE COUGH 939 0.0197
107 INFUSION SITE BRUISING 42 0.0194
108 SINUS PAIN 45 0.0193
109 PULMONARY INFARCTION 45 0.0190
110 INCREASED BRONCHIAL SECRETION 48 0.0187
111 PNEUMOMEDIASTINUM 33 0.0182
112 BLOOD PRESSURE SYSTOLIC ABNORMAL 45 0.0182
113 EOSINOPHILIA 319 0.0182
114 CHRONIC KIDNEY DISEASE 1378 0.0181
115 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 90 0.0180
116 ECONOMIC PROBLEM 273 0.0180
117 MULTIPLE-DRUG RESISTANCE 55 0.0177
118 PATHOGEN RESISTANCE 160 0.0175
119 PULMONARY FIBROSIS 335 0.0174
120 ACTINIC KERATOSIS 45 0.0173
121 RHINOVIRUS INFECTION 67 0.0172
122 ANHEDONIA 448 0.0170
123 VAGINAL DISCHARGE 169 0.0167
124 PNEUMONIA BACTERIAL 153 0.0167
125 METHAEMOGLOBINAEMIA 38 0.0164
126 IMPAIRED QUALITY OF LIFE 236 0.0164
127 ASPERGILLUS INFECTION 107 0.0163
128 WOUND COMPLICATION 55 0.0160
129 INFUSION SITE PRURITUS 50 0.0158
130 BRONCHOPULMONARY ASPERGILLOSIS 122 0.0157
131 BLOOD PRESSURE DIASTOLIC ABNORMAL 40 0.0157
132 ASTHMA 1775 0.0157
133 PSEUDOMEMBRANOUS COLITIS 35 0.0157
134 PARAESTHESIA ORAL 221 0.0153
135 DRUG RESISTANCE 386 0.0150
136 LUNG CONSOLIDATION 42 0.0150
137 ELECTROCARDIOGRAM QT PROLONGED 538 0.0149
138 HYPOXIA 520 0.0148
139 ARTERIOSCLEROSIS 138 0.0146
140 INFUSION SITE HAEMORRHAGE 48 0.0146
141 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 759 0.0145
142 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 697 0.0145
143 BLOOD IMMUNOGLOBULIN E INCREASED 35 0.0144
144 LIP OEDEMA 60 0.0142
145 LOW BIRTH WEIGHT BABY 112 0.0141
146 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 773 0.0141
147 LUNG NEOPLASM 60 0.0140
148 HYPERCHOLESTEROLAEMIA 135 0.0140
149 FLANK PAIN 130 0.0139
150 LONG QT SYNDROME 33 0.0138
151 PNEUMONIA FUNGAL 54 0.0137
152 THROMBOPHLEBITIS SUPERFICIAL 41 0.0135
153 PLATELET COUNT INCREASED 175 0.0134
154 PREMATURE BABY 404 0.0134
155 LUNG DISORDER 652 0.0133
156 PNEUMONIA VIRAL 42 0.0132
157 PULMONARY MASS 196 0.0131
158 TORSADE DE POINTES 103 0.0131
159 OESOPHAGEAL CANDIDIASIS 52 0.0130
160 ACUTE RESPIRATORY FAILURE 249 0.0129
161 HYPERTRANSAMINASAEMIA 90 0.0129
162 MULTIPLE ALLERGIES 101 0.0129
163 INFUSION SITE SWELLING 81 0.0129
164 DEPRESSIVE SYMPTOM 45 0.0128
165 DYSPNOEA EXERTIONAL 479 0.0127
166 PARANASAL SINUS DISCOMFORT 48 0.0127
167 SUSPECTED OFF LABEL USE 57 0.0126
168 LUNG INFILTRATION 111 0.0126
169 DEVICE INFUSION ISSUE 31 0.0125
170 COVID-19 PNEUMONIA 147 0.0124
171 RESPIRATORY TRACT INFECTION 324 0.0124
172 MASTICATION DISORDER 38 0.0124
173 BILIARY COLIC 36 0.0124
174 ABDOMINAL MASS 33 0.0123
175 THERAPEUTIC AGENT TOXICITY 41 0.0123
176 TOXIC EPIDERMAL NECROLYSIS 186 0.0122
177 RESPIRATION ABNORMAL 84 0.0122
178 HEPATIC CYTOLYSIS 155 0.0121
179 THERMAL BURN 86 0.0121
180 ORGANISING PNEUMONIA 60 0.0121
181 EXERCISE TOLERANCE DECREASED 69 0.0120
182 ORTHOPNOEA 38 0.0119
183 UPPER RESPIRATORY TRACT INFECTION 539 0.0117
184 EOSINOPHIL COUNT INCREASED 97 0.0116
185 INFUSION SITE ERYTHEMA 98 0.0116
186 GASTROOESOPHAGEAL REFLUX DISEASE 933 0.0116
187 OSTEOPENIA 175 0.0115
188 ASTHMATIC CRISIS 42 0.0115
189 SECRETION DISCHARGE 144 0.0115
190 OBESITY 182 0.0114
191 EMPHYSEMA 115 0.0114
192 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 808 0.0113
193 ACUTE RESPIRATORY DISTRESS SYNDROME 200 0.0113
194 MIXED LIVER INJURY 34 0.0113
195 RENAL TUBULAR NECROSIS 110 0.0112
196 ODYNOPHAGIA 65 0.0109
197 ATELECTASIS 105 0.0109
198 ASPIRATION 118 0.0108
199 NODULE 138 0.0106
200 BRONCHIOLITIS 37 0.0105
201 LUNG TRANSPLANT 37 0.0104
202 SNORING 39 0.0103
203 SNEEZING 231 0.0103
204 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 80 0.0103
205 TUBULOINTERSTITIAL NEPHRITIS 193 0.0103
206 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 34 0.0103
207 APPETITE DISORDER 68 0.0102
208 CHRONIC GRAFT VERSUS HOST DISEASE 37 0.0102
209 CLOSTRIDIUM DIFFICILE COLITIS 108 0.0102
210 MULTIPLE INJURIES 63 0.0100
211 MICTURITION URGENCY 114 0.0100
212 CHOLELITHIASIS 320 0.0097
213 DEAFNESS 255 0.0097
214 GALLBLADDER DISORDER 174 0.0097
215 SEASONAL ALLERGY 137 0.0097
216 RESPIRATORY SYNCYTIAL VIRUS INFECTION 84 0.0096
217 SINUS CONGESTION 130 0.0096
218 CACHEXIA 49 0.0095
219 BLOOD CALCIUM INCREASED 83 0.0095
220 HYPOGAMMAGLOBULINAEMIA 62 0.0094
221 STEVENS-JOHNSON SYNDROME 209 0.0094
222 INFUSION SITE PAIN 121 0.0094
223 STILLBIRTH 45 0.0093
224 CUTANEOUS VASCULITIS 34 0.0093
225 ENTEROCOCCAL INFECTION 45 0.0093
226 LOWER RESPIRATORY TRACT INFECTION 422 0.0093
227 GRANULOMA 32 0.0092
228 TACHYPNOEA 125 0.0092
229 DRUG-INDUCED LIVER INJURY 288 0.0092
230 HYPERVENTILATION 53 0.0091
231 ACUTE KIDNEY INJURY 1393 0.0091
232 PULMONARY CONGESTION 120 0.0091
233 PNEUMOTHORAX 144 0.0091
234 INJURY 638 0.0091
235 HEPATIC NECROSIS 34 0.0090
236 SWOLLEN TONGUE 278 0.0089
237 ABDOMINAL TENDERNESS 44 0.0089
238 SQUAMOUS CELL CARCINOMA OF SKIN 52 0.0086
239 DYSPHONIA 503 0.0086
240 RHINITIS 69 0.0085
241 HEPATOTOXICITY 190 0.0085
242 KLEBSIELLA INFECTION 43 0.0085
243 SPINAL CORD COMPRESSION 33 0.0085
244 CHOLECYSTITIS ACUTE 48 0.0085
245 LEUKOCYTOSIS 152 0.0084
246 BRONCHITIS 619 0.0084
247 COUGH 2344 0.0083
248 NASAL CONGESTION 491 0.0083
249 ECCHYMOSIS 57 0.0083
250 RENAL CYST 66 0.0083
251 RESPIRATORY TRACT CONGESTION 131 0.0082
252 LEFT VENTRICULAR HYPERTROPHY 35 0.0082
253 SENSITIVITY TO WEATHER CHANGE 43 0.0082
254 PNEUMOCYSTIS JIROVECII PNEUMONIA 82 0.0082
255 RESPIRATORY FAILURE 595 0.0082
256 CYTOMEGALOVIRUS INFECTION REACTIVATION 36 0.0081
257 PHARYNGITIS 101 0.0081
258 SPINAL OSTEOARTHRITIS 71 0.0081
259 FREQUENT BOWEL MOVEMENTS 218 0.0081
260 TRICUSPID VALVE INCOMPETENCE 64 0.0080
261 OXYGEN SATURATION DECREASED 449 0.0080
262 HEPATITIS CHOLESTATIC 48 0.0080
263 SINUS DISORDER 157 0.0079
264 LACRIMATION INCREASED 239 0.0079
265 SCHIZOPHRENIA 96 0.0079
266 RESPIRATORY DISTRESS 217 0.0079
267 MATERNAL EXPOSURE DURING PREGNANCY 698 0.0078
268 INSURANCE ISSUE 119 0.0078
269 INCORRECT DRUG ADMINISTRATION RATE 33 0.0077
270 CANDIDIASIS 31 0.0077
271 CHEST DISCOMFORT 790 0.0077
272 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216 0.0076
273 EYE PRURITUS 256 0.0076
274 BLOOD POTASSIUM DECREASED 229 0.0076
275 PROCEDURAL PAIN 210 0.0076
276 HIATUS HERNIA 98 0.0076
277 TONGUE DISCOLOURATION 33 0.0075
278 BLOOD TEST ABNORMAL 106 0.0075
279 FOETAL DEATH 39 0.0075
280 ABSCESS LIMB 32 0.0075
281 RHINORRHOEA 485 0.0075
282 NASAL DRYNESS 47 0.0075
283 CHOLECYSTITIS 89 0.0075
284 BACTERIAL INFECTION 139 0.0074
285 HYPERBILIRUBINAEMIA 77 0.0074
286 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 191 0.0074
287 MITRAL VALVE INCOMPETENCE 84 0.0074
288 RASH MACULO-PAPULAR 165 0.0074
289 ISCHAEMIA 34 0.0074
290 DRUG INTOLERANCE 713 0.0074
291 HYPERLIPIDAEMIA 88 0.0074
292 PULMONARY TOXICITY 52 0.0073
293 PNEUMONIA 2379 0.0073
294 RESPIRATORY RATE INCREASED 65 0.0073
295 PULMONARY EMBOLISM 695 0.0073
296 OSTEOPOROSIS 300 0.0073
297 TINNITUS 335 0.0073
298 TRANSAMINASES INCREASED 162 0.0073
299 HYPERVOLAEMIA 36 0.0073
300 RENAL FAILURE CHRONIC 56 0.0073
301 HYPOTHYROIDISM 232 0.0073
302 INTERVERTEBRAL DISC DEGENERATION 67 0.0072
303 QUALITY OF LIFE DECREASED 97 0.0072
304 VENTRICULAR TACHYCARDIA 119 0.0072
305 STREPTOCOCCAL INFECTION 40 0.0072
306 RESPIRATORY DISORDER 215 0.0072
307 CANDIDA INFECTION 121 0.0072
308 RENAL FAILURE 950 0.0071
309 MENINGITIS ASEPTIC 32 0.0071
310 DEAFNESS UNILATERAL 39 0.0071
311 HYPERKERATOSIS 39 0.0071
312 APHONIA 98 0.0070
313 RENAL INJURY 208 0.0070
314 BRONCHOSPASM 98 0.0069
315 TRANSPLANT REJECTION 55 0.0069
316 BLOOD BILIRUBIN INCREASED 185 0.0068
317 CARDIOMYOPATHY 101 0.0068
318 STAPHYLOCOCCAL INFECTION 225 0.0068
319 SKIN LACERATION 74 0.0068
320 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 51 0.0068
321 MALNUTRITION 76 0.0068
322 DRUG INTERACTION 1077 0.0068
323 SINUSITIS 695 0.0068
324 DECREASED ACTIVITY 73 0.0068
325 DYSLIPIDAEMIA 34 0.0067
326 CARDIOMEGALY 82 0.0067
327 CHOLESTASIS 128 0.0067
328 HYPERTRIGLYCERIDAEMIA 39 0.0067
329 DEEP VEIN THROMBOSIS 432 0.0066
330 JOINT INJURY 142 0.0066
331 NEUTROPENIC SEPSIS 47 0.0066
332 VENTRICULAR FIBRILLATION 73 0.0066
333 HAEMODYNAMIC INSTABILITY 50 0.0066
334 ORAL DISORDER 48 0.0065
335 LYMPHOEDEMA 45 0.0065
336 INTERNATIONAL NORMALISED RATIO INCREASED 185 0.0065
337 HEPATITIS ACUTE 42 0.0065
338 HERPES SIMPLEX 42 0.0065
339 HEPATOMEGALY 63 0.0064
340 BACTERAEMIA 76 0.0064
341 DERMATITIS CONTACT 73 0.0064
342 COLITIS 242 0.0064
343 IMMUNOSUPPRESSION 56 0.0063
344 POST-TRAUMATIC STRESS DISORDER 42 0.0063
345 HAEMOLYTIC ANAEMIA 56 0.0062
346 INCREASED UPPER AIRWAY SECRETION 32 0.0062
347 ACUTE HEPATIC FAILURE 85 0.0062
348 ANGIOEDEMA 274 0.0062
349 SWELLING FACE 403 0.0062
350 VITAMIN D DEFICIENCY 60 0.0061
351 DYSPNOEA 3479 0.0061
352 PULMONARY HAEMORRHAGE 48 0.0061
353 TENDON DISORDER 40 0.0061
354 GRAFT VERSUS HOST DISEASE 44 0.0061
355 GINGIVITIS 33 0.0061
356 EAR INFECTION 162 0.0061
357 CONDITION AGGRAVATED 1836 0.0060
358 PNEUMONITIS 164 0.0060
359 WRIST FRACTURE 72 0.0060
360 ELECTROCARDIOGRAM ABNORMAL 47 0.0060
361 EMOTIONAL DISTRESS 723 0.0060
362 MIDDLE INSOMNIA 111 0.0059
363 EAR DISCOMFORT 61 0.0059
364 VIRAL INFECTION 197 0.0059
365 HAEMATOCRIT DECREASED 117 0.0059
366 HYDROCEPHALUS 32 0.0059
367 EAR PAIN 114 0.0059
368 BLOOD PRESSURE SYSTOLIC INCREASED 114 0.0058
369 SINUS TACHYCARDIA 83 0.0058
370 DUODENAL ULCER 41 0.0058
371 SINUS BRADYCARDIA 56 0.0058
372 MULTI-ORGAN FAILURE 100 0.0058
373 ANOSMIA 83 0.0057
374 RECTAL HAEMORRHAGE 246 0.0057
375 PLEURISY 34 0.0057
376 CORONARY ARTERY DISEASE 173 0.0057
377 PAPULE 40 0.0057
378 STRESS CARDIOMYOPATHY 33 0.0057
379 PULMONARY HYPERTENSION 118 0.0057
380 TENDERNESS 59 0.0057
381 INFLUENZA 627 0.0056
382 DENTAL CARIES 62 0.0056
383 BLOOD CREATININE INCREASED 363 0.0056
384 PLEURAL EFFUSION 337 0.0055
385 SUPRAVENTRICULAR TACHYCARDIA 53 0.0055
386 EYE IRRITATION 318 0.0055
387 FOETAL EXPOSURE DURING PREGNANCY 448 0.0055
388 ACIDOSIS 42 0.0055
389 POSTOPERATIVE WOUND INFECTION 37 0.0055
390 RENAL FAILURE ACUTE 232 0.0055
391 INFUSION SITE EXTRAVASATION 34 0.0055
392 INFUSION RELATED REACTION 362 0.0055
393 PHARYNGITIS STREPTOCOCCAL 59 0.0054
394 PRODUCT USE IN UNAPPROVED INDICATION 1343 0.0054
395 SLEEP APNOEA SYNDROME 103 0.0054
396 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
397 ADRENAL INSUFFICIENCY 65 0.0054
398 IMPAIRED GASTRIC EMPTYING 73 0.0053
399 ANXIETY 1523 0.0053
400 PRODUCT ADMINISTRATION INTERRUPTED 42 0.0053
401 CYANOSIS 84 0.0053
402 RIB FRACTURE 109 0.0053
403 APHTHOUS ULCER 41 0.0053
404 BLOOD PRESSURE DIASTOLIC DECREASED 39 0.0053
405 GASTRITIS 139 0.0053
406 HEPATIC STEATOSIS 98 0.0053
407 COVID-19 922 0.0052
408 HAEMATOCHEZIA 290 0.0052
409 SKIN MASS 35 0.0052
410 IMMUNODEFICIENCY 78 0.0052
411 CONJUNCTIVITIS 97 0.0052
412 OROPHARYNGEAL PAIN 484 0.0052
413 AGRANULOCYTOSIS 97 0.0052
414 MYOPATHY 45 0.0052
415 REFUSAL OF TREATMENT BY PATIENT 34 0.0052
416 TOOTH ABSCESS 53 0.0052
417 COLITIS ISCHAEMIC 35 0.0052
418 TRANSIENT ISCHAEMIC ATTACK 175 0.0052
419 BODY TEMPERATURE DECREASED 51 0.0052
420 HAEMOLYSIS 40 0.0052
421 HEARING IMPAIRED 31 0.0052
422 BODY TEMPERATURE INCREASED 105 0.0051
423 ATRIAL SEPTAL DEFECT 43 0.0051
424 INFECTION 743 0.0051
425 THERAPY INTERRUPTED 366 0.0051
426 ILLNESS 527 0.0051
427 MENTAL STATUS CHANGES 142 0.0051
428 OFF LABEL USE 4469 0.0051
429 THERAPY NON-RESPONDER 229 0.0051
430 INTENTIONAL DOSE OMISSION 145 0.0051
431 RASH PUSTULAR 37 0.0051
432 BRAIN OEDEMA 64 0.0051
433 DYSPEPSIA 497 0.0050
434 DRUG ERUPTION 89 0.0050
435 CHOLECYSTECTOMY 57 0.0050
436 LIVER FUNCTION TEST INCREASED 107 0.0050
437 SKIN LESION 136 0.0050
438 OESOPHAGITIS 54 0.0049
439 ERYTHEMA MULTIFORME 46 0.0049
440 POOR VENOUS ACCESS 51 0.0049
441 ELECTROLYTE IMBALANCE 57 0.0049
442 OEDEMA PERIPHERAL 597 0.0049
443 RENAL IMPAIRMENT 410 0.0049
444 COLITIS ULCERATIVE 218 0.0049
445 EXTRASYSTOLES 34 0.0049
446 PRODUCT DISTRIBUTION ISSUE 45 0.0048
447 MUSCULOSKELETAL CHEST PAIN 75 0.0048
448 OPTIC NEURITIS 44 0.0048
449 EXOSTOSIS 44 0.0048
450 ABDOMINAL PAIN 1118 0.0048
451 COAGULOPATHY 80 0.0048
452 HAND FRACTURE 34 0.0048
453 BLOOD ALKALINE PHOSPHATASE INCREASED 119 0.0048
454 PYREXIA 1657 0.0048
455 DIVERTICULUM 34 0.0048
456 AUTOIMMUNE HEPATITIS 33 0.0047
457 JAUNDICE 127 0.0047
458 FUNGAL INFECTION 157 0.0047
459 MYASTHENIA GRAVIS 38 0.0047
460 RHABDOMYOLYSIS 195 0.0047
461 PAROSMIA 35 0.0046
462 PANCYTOPENIA 259 0.0046
463 LYMPHADENOPATHY 164 0.0046
464 PRODUCT DOSE OMISSION IN ERROR 131 0.0046
465 DISEASE RECURRENCE 220 0.0046
466 BONE DISORDER 84 0.0046
467 GASTROENTERITIS VIRAL 83 0.0046
468 FEAR 122 0.0045
469 THROAT IRRITATION 203 0.0045
470 ANAEMIA 862 0.0045
471 SLEEP DISORDER 318 0.0045
472 SEPTIC SHOCK 196 0.0045
473 PREGNANCY 90 0.0045
474 HEPATITIS 115 0.0045
475 DEFORMITY 42 0.0045
476 AGEUSIA 112 0.0045
477 LIVER INJURY 110 0.0045
478 EYELID OEDEMA 52 0.0045
479 BONE DENSITY DECREASED 140 0.0045
480 INTERVERTEBRAL DISC PROTRUSION 97 0.0044
481 WEIGHT DECREASED 1233 0.0044
482 NASAL DISCOMFORT 35 0.0044
483 DRUG LEVEL INCREASED 73 0.0044
484 PSYCHOTIC DISORDER 130 0.0044
485 TENDONITIS 68 0.0044
486 NEPHROPATHY 41 0.0044
487 CHEST PAIN 808 0.0044
488 JOINT DISLOCATION 46 0.0043
489 VENTRICULAR EXTRASYSTOLES 45 0.0043
490 GENERAL PHYSICAL HEALTH DETERIORATION 501 0.0043
491 HALLUCINATION, VISUAL 91 0.0043
492 ORAL HERPES 84 0.0043
493 CHROMATURIA 97 0.0043
494 HALLUCINATION, AUDITORY 68 0.0043
495 FOOD ALLERGY 33 0.0043
496 OSTEOARTHRITIS 181 0.0043
497 DISSEMINATED INTRAVASCULAR COAGULATION 60 0.0043
498 ATRIAL FIBRILLATION 414 0.0042
499 SPINAL COMPRESSION FRACTURE 35 0.0042
500 MULTIPLE FRACTURES 69 0.0042
501 PERICARDIAL EFFUSION 97 0.0042
502 GASTROENTERITIS 61 0.0042
503 HEPATIC FAILURE 126 0.0042
504 BLOOD ALBUMIN DECREASED 33 0.0042
505 FACIAL PAIN 37 0.0041
506 OSTEOMYELITIS 75 0.0041
507 LUNG NEOPLASM MALIGNANT 170 0.0041
508 DRY THROAT 42 0.0041
509 EYE PAIN 233 0.0041
510 NIGHT SWEATS 133 0.0041
511 IRON DEFICIENCY ANAEMIA 38 0.0041
512 URTICARIA 688 0.0041
513 HYPERSENSITIVITY 762 0.0041
514 FACE OEDEMA 69 0.0041
515 EXPOSURE DURING PREGNANCY 254 0.0041
516 ENCEPHALOPATHY 100 0.0041
517 RED BLOOD CELL SEDIMENTATION RATE INCREASED 45 0.0041
518 METABOLIC ACIDOSIS 130 0.0041
519 PULMONARY OEDEMA 182 0.0041
520 PHOTOSENSITIVITY REACTION 67 0.0041
521 CARDIAC ARREST 334 0.0040
522 LIGAMENT SPRAIN 40 0.0040
523 SEPSIS 451 0.0040
524 EYE DISCHARGE 42 0.0040
525 GASTROINTESTINAL DISORDER 362 0.0040
526 RASH ERYTHEMATOUS 193 0.0040
527 DEVICE RELATED INFECTION 62 0.0040
528 TREATMENT NONCOMPLIANCE 220 0.0040
529 BRAIN FOG 63 0.0040
530 HEPATIC ENZYME INCREASED 274 0.0040
531 HEART RATE INCREASED 398 0.0040
532 MYOSITIS 36 0.0040
533 ATRIAL FLUTTER 32 0.0040
534 OROPHARYNGEAL DISCOMFORT 36 0.0040
535 SCAR 68 0.0040
536 ROTATOR CUFF SYNDROME 51 0.0040
537 ORAL DISCOMFORT 55 0.0040
538 TACHYCARDIA 349 0.0039
539 OCULAR DISCOMFORT 44 0.0039
540 GASTROINTESTINAL PAIN 43 0.0039
541 DRUG PRESCRIBING ERROR 75 0.0039
542 CLOSTRIDIUM DIFFICILE INFECTION 85 0.0039
543 ANAL INCONTINENCE 35 0.0039
544 OCULAR HYPERAEMIA 184 0.0039
545 BLOOD PRESSURE FLUCTUATION 93 0.0039
546 PANCREATITIS ACUTE 87 0.0039
547 PAIN 2376 0.0039
548 TREATMENT FAILURE 320 0.0039
549 NASOPHARYNGITIS 709 0.0038
550 ABDOMINAL PAIN LOWER 97 0.0038
551 ANURIA 33 0.0038
552 NEPHROPATHY TOXIC 43 0.0038
553 WOUND 107 0.0038
554 SHOCK 88 0.0038
555 MUSCLE STRAIN 33 0.0038
556 THROMBOSIS 306 0.0038
557 MOUTH ULCERATION 80 0.0038
558 BURSITIS 46 0.0038
559 PALLOR 103 0.0038
560 BLOOD SODIUM DECREASED 71 0.0038
561 HEART RATE IRREGULAR 85 0.0038
562 CYTOPENIA 46 0.0038
563 CELLULITIS 189 0.0037
564 SKIN INFECTION 42 0.0037
565 OEDEMA 203 0.0037
566 PURPURA 33 0.0037
567 UPPER LIMB FRACTURE 74 0.0037
568 HEART RATE DECREASED 130 0.0037
569 ALANINE AMINOTRANSFERASE INCREASED 227 0.0037
570 CARDIOGENIC SHOCK 53 0.0037
571 LYMPHOPENIA 52 0.0037
572 ASPARTATE AMINOTRANSFERASE INCREASED 195 0.0037
573 CYTOMEGALOVIRUS INFECTION 61 0.0037
574 COELIAC DISEASE 36 0.0037
575 DERMATITIS ALLERGIC 46 0.0037
576 THROMBOCYTOPENIA 406 0.0036
577 ANAPHYLACTIC REACTION 200 0.0036
578 MYOCLONUS 43 0.0036
579 EYE SWELLING 134 0.0036
580 ABDOMINAL PAIN UPPER 734 0.0036
581 RETCHING 76 0.0036
582 PALPITATIONS 416 0.0035
583 LACTIC ACIDOSIS 115 0.0035
584 EYE INFECTION 40 0.0035
585 CONSTIPATION 772 0.0035
586 MENTAL DISORDER 154 0.0035
587 PRODUCT PRESCRIBING ISSUE 77 0.0035
588 BLOOD UREA INCREASED 59 0.0035
589 HYPERKALAEMIA 123 0.0035
590 BIPOLAR DISORDER 38 0.0035
591 TOOTH INFECTION 46 0.0035
592 ANKLE FRACTURE 54 0.0035
593 FOOT FRACTURE 66 0.0035
594 HAEMATURIA 119 0.0035
595 PHARYNGEAL SWELLING 34 0.0035
596 HEPATOCELLULAR INJURY 49 0.0035
597 GOUT 62 0.0035
598 BLOOD IRON DECREASED 41 0.0035
599 PETECHIAE 36 0.0034
600 HYPOKALAEMIA 159 0.0034
601 EMOTIONAL DISORDER 106 0.0034
602 HAEMORRHAGE 359 0.0034
603 NEPHROLITHIASIS 157 0.0034
604 SPLENOMEGALY 40 0.0034
605 LIVER FUNCTION TEST ABNORMAL 99 0.0034
606 GENERALISED OEDEMA 42 0.0034
607 HYPERTENSION 717 0.0034
608 LEUKOPENIA 169 0.0034
609 MUSCULOSKELETAL DISCOMFORT 58 0.0034
610 IRRITABLE BOWEL SYNDROME 72 0.0034
611 ANGINA PECTORIS 96 0.0033
612 LUNG INFECTION 52 0.0033
613 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
614 HYPOPHAGIA 85 0.0033
615 KIDNEY INFECTION 65 0.0033
616 PRODUCT DOSE OMISSION ISSUE 972 0.0033
617 ERYTHEMA 679 0.0033
618 VOMITING 1550 0.0033
619 DELIRIUM 114 0.0033
620 NO ADVERSE EVENT 595 0.0033
621 ULCER 52 0.0033
622 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 232 0.0033
623 DISCOMFORT 198 0.0032
624 FOLLICULITIS 34 0.0032
625 NECK PAIN 181 0.0032
626 HYPOMAGNESAEMIA 45 0.0032
627 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
628 DRUG INEFFECTIVE 4257 0.0032
629 RASH PRURITIC 175 0.0032
630 EJECTION FRACTION DECREASED 50 0.0032
631 CARPAL TUNNEL SYNDROME 45 0.0032
632 CARDIAC FAILURE CONGESTIVE 258 0.0032
633 DEPRESSION 729 0.0032
634 BRADYCARDIA 169 0.0032
635 TOOTH LOSS 66 0.0032
636 HAEMORRHOIDS 62 0.0032
637 DISEASE PROGRESSION 376 0.0032
638 TOXIC SKIN ERUPTION 32 0.0032
639 TOOTH FRACTURE 35 0.0032
640 PRESYNCOPE 77 0.0032
641 HYPONATRAEMIA 178 0.0032
642 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
643 DYSURIA 116 0.0031
644 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
645 NAUSEA 2491 0.0031
646 CYSTITIS 100 0.0031
647 HOSPICE CARE 31 0.0031
648 SCIATICA 50 0.0031
649 DIARRHOEA 2024 0.0031
650 LIMB INJURY 85 0.0031
651 DEPRESSED MOOD 165 0.0031
652 PHARYNGEAL OEDEMA 48 0.0031
653 ORTHOSTATIC HYPOTENSION 54 0.0031
654 PANIC ATTACK 113 0.0031
655 TOOTHACHE 56 0.0031
656 BLOOD POTASSIUM INCREASED 50 0.0031
657 URINARY TRACT INFECTION 525 0.0031
658 HYPERCALCAEMIA 38 0.0031
659 MASS 43 0.0031
660 HYPERGLYCAEMIA 112 0.0031
661 CATARACT 183 0.0031
662 PAIN IN JAW 87 0.0031
663 HYPOACUSIS 132 0.0031
664 DYSPHAGIA 291 0.0031
665 DRY EYE 153 0.0031
666 RENAL DISORDER 142 0.0030
667 HIP FRACTURE 98 0.0030
668 RASH 1327 0.0030
669 HYPOTENSION 607 0.0030
670 HEADACHE 1896 0.0030
671 CHILLS 353 0.0030
672 GLOMERULAR FILTRATION RATE DECREASED 37 0.0030
673 SKIN DISCOLOURATION 138 0.0030
674 TREMOR 497 0.0030
675 CYTOKINE RELEASE SYNDROME 60 0.0030
676 MALAISE 1310 0.0030
677 INCORRECT DRUG ADMINISTRATION DURATION 84 0.0030
678 INFLAMMATION 153 0.0030
679 ASTHENIA 1099 0.0029
680 RESTLESS LEGS SYNDROME 53 0.0029
681 C-REACTIVE PROTEIN INCREASED 106 0.0029
682 ORAL PAIN 65 0.0029
683 NEUROPATHY PERIPHERAL 276 0.0029
684 PRODUCT QUALITY ISSUE 394 0.0029
685 FEBRILE NEUTROPENIA 192 0.0029
686 THERAPY PARTIAL RESPONDER 45 0.0029
687 THROAT TIGHTNESS 78 0.0029
688 SARS-COV-2 TEST POSITIVE 38 0.0029
689 ARTHRITIS 226 0.0029
690 ANAPHYLACTIC SHOCK 74 0.0029
691 BLOOD PRESSURE ABNORMAL 57 0.0029
692 ATAXIA 34 0.0029
693 FAECES DISCOLOURED 62 0.0029
694 GASTRIC ULCER 54 0.0028
695 BACK PAIN 660 0.0028
696 PERIPHERAL COLDNESS 39 0.0028
697 FIBROMYALGIA 69 0.0028
698 BURNING SENSATION 199 0.0028
699 COLD SWEAT 50 0.0028
700 HAEMOGLOBIN DECREASED 290 0.0028
701 CARDIO-RESPIRATORY ARREST 118 0.0028
702 HAEMATOMA 73 0.0028
703 DEHYDRATION 375 0.0028
704 SEROTONIN SYNDROME 54 0.0028
705 DECREASED APPETITE 648 0.0028
706 BLOOD PRESSURE INCREASED 425 0.0028
707 HEMIPARESIS 47 0.0028
708 INCREASED APPETITE 53 0.0028
709 VERTIGO 169 0.0028
710 ABDOMINAL DISTENSION 289 0.0028
711 SYNCOPE 277 0.0028
712 HOSPITALISATION 424 0.0028
713 NEURALGIA 67 0.0028
714 HYPOCALCAEMIA 52 0.0027
715 SPINAL FRACTURE 55 0.0027
716 LABORATORY TEST ABNORMAL 81 0.0027
717 PAIN IN EXTREMITY 806 0.0027
718 LIP SWELLING 91 0.0027
719 CONTUSION 263 0.0027
720 ABDOMINAL DISCOMFORT 456 0.0027
721 UNRESPONSIVE TO STIMULI 70 0.0027
722 PHOTOPHOBIA 51 0.0027
723 LOCALISED INFECTION 65 0.0027
724 DYSGEUSIA 199 0.0027
725 DIVERTICULITIS 74 0.0027
726 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59 0.0027
727 BONE LOSS 40 0.0027
728 CYST 33 0.0027
729 HYPERHIDROSIS 342 0.0027
730 APHASIA 80 0.0026
731 INTERSTITIAL LUNG DISEASE 128 0.0026
732 BLISTER 148 0.0026
733 RASH MACULAR 92 0.0026
734 BASAL CELL CARCINOMA 41 0.0026
735 EPISTAXIS 196 0.0026
736 BONE MARROW FAILURE 53 0.0026
737 MUSCULOSKELETAL STIFFNESS 228 0.0026
738 FATIGUE 2021 0.0026
739 WEIGHT INCREASED 579 0.0026
740 IMMUNE SYSTEM DISORDER 34 0.0026
741 DERMATITIS 54 0.0026
742 LETHARGY 148 0.0026
743 VISION BLURRED 353 0.0026
744 DYSSTASIA 75 0.0026
745 TASTE DISORDER 52 0.0026
746 HALLUCINATION 193 0.0026
747 JOINT STIFFNESS 67 0.0026
748 ASCITES 75 0.0025
749 DIABETES MELLITUS 194 0.0025
750 PRODUCT USE COMPLAINT 40 0.0025
751 EATING DISORDER 54 0.0025
752 DYSARTHRIA 95 0.0025
753 FLATULENCE 143 0.0025
754 PRURITUS 968 0.0025
755 CHOKING 49 0.0025
756 TYPE 2 DIABETES MELLITUS 84 0.0025
757 HYPERTHYROIDISM 36 0.0025
758 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 448 0.0025
759 SKIN REACTION 35 0.0025
760 INSOMNIA 661 0.0025
761 PNEUMONIA ASPIRATION 62 0.0025
762 TARDIVE DYSKINESIA 70 0.0025
763 IMPAIRED HEALING 81 0.0025
764 BLOOD CHOLESTEROL INCREASED 115 0.0025
765 DIALYSIS 35 0.0025
766 SKIN EXFOLIATION 208 0.0025
767 ABSCESS 39 0.0024
768 BEDRIDDEN 32 0.0024
769 ABORTION SPONTANEOUS 97 0.0024
770 MIGRAINE 231 0.0024
771 AKATHISIA 33 0.0024
772 MUSCULOSKELETAL PAIN 126 0.0024
773 PANCREATITIS 127 0.0024
774 NEUROTOXICITY 42 0.0024
775 DIZZINESS 1195 0.0024
776 HYPOAESTHESIA ORAL 36 0.0024
777 ARRHYTHMIA 113 0.0024
778 HERPES ZOSTER 137 0.0024
779 AGITATION 175 0.0024
780 GAIT DISTURBANCE 456 0.0024
781 MANIA 39 0.0024
782 SENSORY DISTURBANCE 38 0.0024
783 SWELLING 221 0.0024
784 DRUG DOSE OMISSION 390 0.0024
785 POOR QUALITY SLEEP 50 0.0023
786 RASH PAPULAR 52 0.0023
787 ECZEMA 121 0.0023
788 ILL-DEFINED DISORDER 140 0.0023
789 FALL 766 0.0023
790 IMPAIRED WORK ABILITY 49 0.0023
791 POLLAKIURIA 95 0.0023
792 AGGRESSION 114 0.0023
793 DRY MOUTH 184 0.0023
794 ABASIA 56 0.0023
795 BLOOD TRIGLYCERIDES INCREASED 40 0.0023
796 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
797 CRYING 81 0.0022
798 HERNIA 43 0.0022
799 COORDINATION ABNORMAL 31 0.0022
800 FEEDING DISORDER 45 0.0022
801 BLOOD URINE PRESENT 42 0.0022
802 THYROID DISORDER 34 0.0022
803 COMPLICATION ASSOCIATED WITH DEVICE 32 0.0022
804 SURGERY 129 0.0022
805 FLUID OVERLOAD 32 0.0022
806 PERIPHERAL SWELLING 337 0.0022
807 BALANCE DISORDER 189 0.0022
808 MUSCLE SPASMS 401 0.0022
809 BONE PAIN 128 0.0022
810 COGNITIVE DISORDER 102 0.0022
811 MELAENA 48 0.0022
812 SKIN ULCER 56 0.0022
813 DYSKINESIA 88 0.0022
814 LOSS OF CONSCIOUSNESS 277 0.0022
815 STOMATITIS 131 0.0022
816 TOOTH DISORDER 48 0.0022
817 MOBILITY DECREASED 155 0.0022
818 PROTEINURIA 41 0.0022
819 PRODUCT AVAILABILITY ISSUE 49 0.0021
820 HEAD DISCOMFORT 38 0.0021
821 RED BLOOD CELL COUNT DECREASED 61 0.0021
822 RESTLESSNESS 78 0.0021
823 GLAUCOMA 41 0.0021
824 DISABILITY 42 0.0021
825 MUSCULAR WEAKNESS 241 0.0021
826 CONFUSIONAL STATE 341 0.0021
827 LIVER DISORDER 93 0.0021
828 EXTRAPYRAMIDAL DISORDER 52 0.0021
829 URINARY INCONTINENCE 62 0.0021
830 HEPATIC FUNCTION ABNORMAL 78 0.0021
831 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
832 POST PROCEDURAL COMPLICATION 40 0.0021
833 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 61 0.0021
834 NIGHTMARE 72 0.0021
835 HAEMORRHAGE INTRACRANIAL 31 0.0021
836 LIMB DISCOMFORT 64 0.0021
837 EYE DISORDER 68 0.0021
838 RESPIRATORY ARREST 57 0.0021
839 ARTHRALGIA 855 0.0021
840 CIRCULATORY COLLAPSE 35 0.0021
841 GLOSSODYNIA 46 0.0021
842 ACUTE MYELOID LEUKAEMIA 32 0.0021
843 NEUTROPENIA 279 0.0020
844 THERAPEUTIC RESPONSE SHORTENED 68 0.0020
845 RASH GENERALISED 53 0.0020
846 ACUTE MYOCARDIAL INFARCTION 60 0.0020
847 OSTEONECROSIS OF JAW 50 0.0020
848 INTESTINAL OBSTRUCTION 76 0.0020
849 PARAESTHESIA 317 0.0020
850 URINARY RETENTION 67 0.0020
851 HYPOGLYCAEMIA 97 0.0020
852 CARDIAC DISORDER 187 0.0020
853 AMNESIA 130 0.0020
854 MYALGIA 336 0.0020
855 HAEMATEMESIS 50 0.0020
856 PARANOIA 34 0.0020
857 DISORIENTATION 78 0.0020
858 DIPLOPIA 51 0.0020
859 ROAD TRAFFIC ACCIDENT 82 0.0020
860 DERMATITIS ATOPIC 103 0.0020
861 TOXICITY TO VARIOUS AGENTS 329 0.0019
862 OSTEONECROSIS 64 0.0019
863 MUCOSAL INFLAMMATION 51 0.0019
864 HYPOAESTHESIA 291 0.0019
865 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
866 PSYCHOMOTOR HYPERACTIVITY 32 0.0019
867 PELVIC PAIN 35 0.0019
868 INFLUENZA LIKE ILLNESS 158 0.0019
869 PERICARDITIS 32 0.0019
870 FEELING ABNORMAL 456 0.0019
871 GASTROINTESTINAL HAEMORRHAGE 159 0.0019
872 MENTAL IMPAIRMENT 46 0.0019
873 VISUAL IMPAIRMENT 233 0.0019
874 MEDICATION ERROR 104 0.0019
875 DEPRESSED LEVEL OF CONSCIOUSNESS 74 0.0019
876 HEAD INJURY 59 0.0019
877 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
878 BLINDNESS 75 0.0018
879 NERVOUSNESS 96 0.0018
880 FEELING COLD 51 0.0018
881 PLATELET COUNT DECREASED 195 0.0018
882 UNEVALUABLE EVENT 137 0.0018
883 HEPATIC CIRRHOSIS 34 0.0018
884 ERUCTATION 35 0.0018
885 FLUID RETENTION 92 0.0018
886 CONVULSION 103 0.0018
887 ARTHROPATHY 100 0.0018
888 PRODUCT USE ISSUE 338 0.0018
889 HOT FLUSH 135 0.0018
890 BLOOD PRESSURE DECREASED 119 0.0018
891 PRODUCT ADMINISTRATION ERROR 36 0.0018
892 FEELING HOT 109 0.0018
893 WHITE BLOOD CELL COUNT DECREASED 192 0.0018
894 ADVERSE DRUG REACTION 159 0.0018
895 LOWER LIMB FRACTURE 34 0.0018
896 SKIN DISORDER 59 0.0018
897 PRURITUS GENERALISED 38 0.0018
898 CARDIAC FAILURE 141 0.0018
899 JOINT SWELLING 212 0.0018
900 HYPERSOMNIA 50 0.0017
901 PSORIATIC ARTHROPATHY 70 0.0017
902 GAIT INABILITY 57 0.0017
903 SPEECH DISORDER 89 0.0017
904 MEMORY IMPAIRMENT 233 0.0017
905 DISTURBANCE IN ATTENTION 91 0.0017
906 ANGER 57 0.0017
907 FEMUR FRACTURE 52 0.0017
908 SKIN CANCER 36 0.0017
909 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
910 MOVEMENT DISORDER 53 0.0016
911 MUSCLE TWITCHING 38 0.0016
912 THERAPEUTIC RESPONSE DECREASED 99 0.0016
913 VISUAL ACUITY REDUCED 54 0.0016
914 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
915 CEREBRAL INFARCTION 39 0.0016
916 PRODUCT PRESCRIBING ERROR 38 0.0016
917 MOOD SWINGS 50 0.0016
918 ABNORMAL BEHAVIOUR 62 0.0016
919 CEREBRAL HAEMORRHAGE 56 0.0016
920 ERECTILE DYSFUNCTION 40 0.0016
921 GASTRIC DISORDER 52 0.0015
922 NERVOUS SYSTEM DISORDER 47 0.0015
923 CEREBROVASCULAR ACCIDENT 255 0.0015
924 FLUSHING 153 0.0015
925 EXPOSURE VIA SKIN CONTACT 39 0.0015
926 CARDIOVASCULAR DISORDER 38 0.0015
927 INTENTIONAL PRODUCT USE ISSUE 131 0.0015
928 COMA 71 0.0015
929 DRUG EXPOSURE DURING PREGNANCY 50 0.0015
930 SOMNOLENCE 295 0.0015
931 SUICIDAL IDEATION 132 0.0014
932 NEUTROPHIL COUNT DECREASED 58 0.0014
933 DEVICE DELIVERY SYSTEM ISSUE 38 0.0014
934 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
935 ABNORMAL DREAMS 38 0.0014
936 EPILEPSY 42 0.0014
937 PLASMA CELL MYELOMA 53 0.0014
938 SEIZURE 155 0.0013
939 NEEDLE ISSUE 39 0.0013
940 MYELOSUPPRESSION 48 0.0013
941 ACCIDENTAL OVERDOSE 48 0.0013
942 DRUG ADMINISTRATION ERROR 40 0.0013
943 SUICIDE ATTEMPT 79 0.0013
944 MOOD ALTERED 35 0.0013
945 THERAPEUTIC RESPONSE UNEXPECTED 57 0.0013
946 RHEUMATOID ARTHRITIS 140 0.0012
947 MYOCARDIAL INFARCTION 215 0.0012
948 DRY SKIN 164 0.0012
949 PAIN OF SKIN 33 0.0012
950 IRRITABILITY 73 0.0012
951 ALOPECIA 237 0.0012
952 THERAPEUTIC PRODUCT EFFECT DECREASED 52 0.0012
953 VAGINAL HAEMORRHAGE 50 0.0012
954 EXTRA DOSE ADMINISTERED 46 0.0011
955 WRONG TECHNIQUE IN DRUG USAGE PROCESS 41 0.0011
956 DEATH 967 0.0011
957 INCORRECT DOSE ADMINISTERED 253 0.0011
958 INTENTIONAL PRODUCT MISUSE 97 0.0011
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 222 0.0011
960 BLOOD GLUCOSE INCREASED 199 0.0011
961 INJECTION SITE PRURITUS 70 0.0010
962 NEOPLASM MALIGNANT 68 0.0010
963 ADVERSE EVENT 92 0.0010
964 PSORIASIS 130 0.0010
965 INJECTION SITE SWELLING 75 0.0010
966 INJECTION SITE PAIN 297 0.0010
967 BLOOD GLUCOSE DECREASED 46 0.0010
968 DEVICE ISSUE 85 0.0009
969 NEOPLASM PROGRESSION 32 0.0009
970 INJECTION SITE REACTION 62 0.0009
971 INTENTIONAL OVERDOSE 57 0.0009
972 OVERDOSE 189 0.0009
973 INJECTION SITE MASS 32 0.0009
974 INJECTION SITE BRUISING 69 0.0009
975 SKIN IRRITATION 39 0.0009
976 DEVICE LEAKAGE 36 0.0008
977 UNDERDOSE 56 0.0008
978 DRUG DOSE OMISSION BY DEVICE 60 0.0008
979 THERAPY CESSATION 39 0.0008
980 INJECTION SITE ERYTHEMA 94 0.0008
981 ACNE 56 0.0007
982 ACCIDENTAL EXPOSURE TO PRODUCT 69 0.0007
983 PRODUCT SUBSTITUTION ISSUE 38 0.0007
984 SKIN BURNING SENSATION 47 0.0007
985 MALIGNANT NEOPLASM PROGRESSION 57 0.0006
986 PRODUCT STORAGE ERROR 46 0.0005
987 DRUG DEPENDENCE 76 0.0005
988 INJECTION SITE HAEMORRHAGE 34 0.0004
989 DRUG WITHDRAWAL SYNDROME 37 0.0004
990 DRUG ABUSE 33 0.0004